- Home
- Share Prices
- AQSE Share Prices
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Media & Events
- Brokers
- Finance Tools
- Members
Latest Share Chat
Syncona Share Price (SYNC)
SYNC Share
Price
SYNC Share
News
SYNC Share
Chat
SYNC Share
Trades116
SYNC
Live RNS
SYNC Share
Charts
SYNC Level 2
Console
SYNC Live
Share Price
SYNC Broker
Ratings
SYNC Directors
Deals
SYNC Financial
Diary
SYNC
Fundamentals
SYNC Short
Positions
SYNC
Media
SYNC Information
Share Price Information for Syncona (SYNC)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
207.50
Bid:
207.50
Ask:
209.00
Change: -0.50 (-0.24%)
Spread:
1.50 (0.72%)
Open:
201.00
High:
210.00
Low:
201.00
Prev. Close:
207.50
Last checked at -
Last checked at 
Syncona is an Investment Trust
To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.
Find out MoreWatchlists are a member only feature
Login to your account
Don't have an account? Click here to register.| Syncona Share Price | |
|---|---|
| Price | 207.50 |
| Bid | 207.50 |
| Ask | 209.00 |
| Change | -0.50 (-0.24%) |
| Volume | 206,984 |
| Open | 201.00 |
| High | 210.00 |
| Low | 201.00 |
| Prev. Close | 207.50 |
| Currency | GBX |
| Currency | GBX |
|---|---|
| Issue Country | GG |
| Shares in Issue | 669m |
| Market Capitalisation | £1,389m |
| Market Size | 7,500 |
| 52 Week High | 224.50 |
| 52 Week High Date | 22-Dec-2021 |
| 52 Week Low | 154.00 |
| 52 Week Low Date | 07-Mar-2022 |
| # Trades | 116 |
|---|---|
| Vol. Sold | 147,467 |
| Sold Value | £303,878.84 |
| Vol. Bought | 54,245 |
| Bought Value | £112,565.15 |
| PE Ratio | 156.015 |
| Earnings | 1.33 |
| Dividend | 0.00 |
| Yield | 0.00% |
Recent Share Trades for Syncona (SYNC)
| Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
|---|---|---|---|---|---|---|---|---|
| 08-Aug-22 | 17:57:46 | 207.50 | 1,627 | Unknown* | 207.50 | 209.00 | 3,376 | O Ordinary |
| 08-Aug-22 | 17:55:50 | 207.50 | 2,176 | Unknown* | 207.50 | 209.00 | 4,515 | O Ordinary |
| 08-Aug-22 | 17:39:59 | 207.521 | 66 | Unknown* | 207.50 | 209.00 | 136.96 | O Ordinary |
| 08-Aug-22 | 16:35:44 | 207.50 | 23,310 | Sell* | 207.50 | 209.00 | 48.37k | O Ordinary |
| 08-Aug-22 | 16:35:00 | 207.50 | 22,748 | Sell* | 207.50 | 210.00 | 47.20k | UT Uncrossing Trade |
| 08-Aug-22 | 16:12:20 | 208.25 | 196 | Unknown* | 207.50 | 209.00 | 408.17 | O Ordinary |
| 08-Aug-22 | 16:05:16 | 207.50 | 86 | Sell* | 207.50 | 209.00 | 178.45 | A Automatic Execution |
| 08-Aug-22 | 16:05:16 | 207.50 | 362 | Sell* | 207.50 | 209.00 | 751.15 | A Automatic Execution |
| 08-Aug-22 | 16:05:16 | 208.50 | 449 | Buy* | 207.50 | 209.00 | 936.17 | A Automatic Execution |
| 08-Aug-22 | 16:05:16 | 208.50 | 383 | Buy* | 207.50 | 209.00 | 798.56 | A Automatic Execution |
Directors Deals for Syncona (SYNC)
| Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
|---|---|---|---|---|---|---|---|
| 09-Mar-22 | 09-Mar-22 | Buy | Robert Hutchinson held the position of Independent Non-Executive Director at the time of this trade. Robert Hutchinson | 171.80 | GBX | 26,000 | 94,827 |
| 12-May-21 | 10-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade. Thomas Henderson | 222.12 | GBX | 639,885 | 2,000,000 |
| 12-May-21 | 10-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade. Thomas Henderson | 223.88 | GBX | 3,222,943 | 2,000,000 |
| 12-May-21 | 11-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade. Thomas Henderson | 202.05 | GBX | 2,137,172 | 2,000,000 |
| 06-Apr-21 | 01-Apr-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade. Thomas Henderson | 250.01 | GBX | 317,961 | 2,000,000 |
Share Discussion for Syncona (SYNC)
Syncona
Syncona is a FTSE250 company focused on investing in and building global leaders in life sciences. Its vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.
